Sexually Transmitted Diseases (STD) Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Sexually Transmitted Diseases (STD) Testing Market is segmented By Product Type (Reagents and Kits, Instruments) By Disease Type (Syphilis, Chlamydia, Gonorrhea, Human Immunodeficiency Virus/AIDS, Trichomoniasis, Others) By Location of Test (Laboratory Testing, Point of Care Testing) By End Users (Hospitals, Clinics, Diagnostic Centers, Others)&nbsp;and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global Sexually Transmitted Diseases (STD) Testing Market reached US$ YY&nbsp;billion in 2022 and is expected to reach US$ YY&nbsp;million by 2031&nbsp;growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

A sexually transmitted disease is a serious condition that can develop after having sex. Common STD symptoms include itching and burning around the genital area. Tests for sexually transmitted diseases include blood, urine, or swab tests and the choice of test can depend on the symptoms and the condition.

Common sexually transmitted diseases include syphilis, chlamydia, gonorrhea, human immunodeficiency virus/AIDS, and trichomoniasis. Some STDs like the human immunodeficiency virus (HIV)&nbsp; have no cure and can be life-threatening without treatment.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product Type, Disease Type, Location of Test, End Users
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/sexually-transmitted-diseases-testing-market" target="_blank">Request for Sample</a>&nbsp;

<h2>&nbsp;</h2>

<h3>Market Dynamics</h3>

Increasing prevalence of STDs

The increasing number of sexually transmitted cases acts as a significant driver for market growth. Sexually transmitted diseases (STDs) are very common and millions of new infections occur every year globally. STDs pass from one person to another through vaginal, oral and anal sex.

For instance, according to a World Health Organization (WHO) report published in July 2023, more than 1 million sexually transmitted infections are acquired every day worldwide. An estimated 374 million new STD infections occur annually.

Additionally, The World Health Organization has estimated that every year in Africa there are 3.5 million cases of syphilis, 15 million cases of chlamydial disease, 16 million cases of gonorrhea, and 30 million cases of trichomoniasis.

Furthermore, the global sexually transmitted diseases (STD) testing market is driven by various factors like increasing awareness of STDs, and new product launches are expected to drive the market in the forecast period.

Social stigma and lack of awareness&nbsp;

Social stigma and embarrassment faced by individuals can hamper market growth. People are reluctant to seek STD testing which leads to underdiagnosis of a serious condition. Also, a lack of awareness regarding various sexually transmitted infections can hamper the market growth.

<h3>Segment Analysis</h3>

The global sexually transmitted diseases (STD) testing market is segmented based on product type, disease type, location of test, end users and region.

Reagents and kits accounted for approximately 63.4% of the market share&nbsp;

STD kits allow users to choose between different STD panels, each including a different set of tests. Reagents and kits are expected to hold the largest market share over the period forecast owing to increasing the need for STD testing kits and new product launches.&nbsp;

For instance, in February 2023, Mylab Discovery Solutions launched a range of rapid test kits for STDs namely HIV, HCV, and Syphilis for detection at the point of care

Additionally, in August 2023, iHealth Labs, Inc. launched its Home Collection Kit for HIV and syphilis testing. This kit delivers reliable results of up to 99.9% sensitivity for HIV and 99.5% for syphilis.

<h3>Geographical Analysis</h3>

North America is expected to hold a significant position in the global sexually transmitted diseases (STD) testing market share

The global sexually transmitted diseases (STD) testing market is segmented into North America, Europe, Asia Pacific, South America, Middle East and Africa.&nbsp;

North America has maintained a significant market proportion due to factors such as rising healthcare expenditure, rising awareness, and STD testing launches, this trend is anticipated to continue throughout the forecast period.

For instance, in June 2022, the Centers for Disease Control and Prevention recommended and issued guidelines for screening of sexually transmitted diseases in order to create awareness towards screening programs for STDs and the increasing burden of STDs across the globe.

Additionally, in May 2023, US BioTek Laboratories launched at-home STI Testing by offering laboratory STI panels, including those for PrEP that can be conveniently self-collected in the comfort of a patient&#39;s own home.

<h3>COVID-19 Impact Analysis&nbsp;</h3>

The COVID-19 pandemic has had a significant impact on the global sexually transmitted diseases (STD) testing market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the sexually transmitted diseases (STD) testing market was moderately affected over the forecast period.

<h3>Competitive Landscape</h3>

The major global players in the market include Roche Diagnostics Corporation, Bio-Rad Laboratories, Hologic, Inc., Merck and Company Inc., Becton Dickinson &amp; Company, Cepheid, Inc., Danaher Corporation, Affymetrix, Inc., DiaSorin, Abbott Laboratories among others.

<h3>Key Developments</h3>

<ul>
	<li>In May 2022, Medmira Inc. received a CE mark for its Multiplo Complete Syphilis (TP/nTP) Antibody Test (Multiplo TP/nTP). This approval enables the company to further strengthen its product offering in all markets accepting the CE mark.&nbsp;</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global sexually transmitted diseases (STD) testing market segmentation based on product type, disease type, location of test, end users and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of sexually transmitted diseases (STD) testing market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global sexually transmitted diseases (STD) testing market report would provide approximately 61 tables, 63 figures, and 185 Pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product Type</li>
		<li>Snippet by Disease Type</li>
		<li>Snippet by Location of Test</li>
		<li>Snippet by End Users</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Market Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing prevalence of STDs</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Social stigma and lack of awareness</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Attractiveness Index, By Product Type&nbsp;</li>
		</ol>
		</li>
		<li>Reagents and Kits *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Instruments</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Attractiveness Index, By Disease Type&nbsp;</li>
		</ol>
		</li>
		<li>Syphilis *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Chlamydia</li>
		<li>Gonorrhea</li>
		<li>Human Immunodeficiency Virus/AIDS</li>
		<li>Trichomoniasis</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Location of Test</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test</li>
			<li>Market Attractiveness Index, By Location of Test</li>
		</ol>
		</li>
		<li>Laboratory Testing *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Point of Care Testing</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End Users</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Attractiveness Index, By End Users</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Clinics</li>
		<li>Diagnostic Centers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Roche Diagnostics Corporation
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Bio-Rad Laboratories</li>
		<li>Hologic, Inc.</li>
		<li>Merck and Company Inc</li>
		<li>Becton Dickinson &amp; Company</li>
		<li>Cepheid, Inc.</li>
		<li>Danaher Corporation</li>
		<li>Affymetrix, Inc.</li>
		<li>DiaSorin</li>
		<li>Abbott Laboratories&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 01 Global Sexually Transmitted Diseases (STD) Testing Market Value, 2023, 2027 &amp; 2031, By Product Type, ($Million)

Table 02 Global Sexually Transmitted Diseases (STD) Testing Market Value 2023, 2027 &amp; 2031, By Location of Test, ($Million)

Table 03 Global Sexually Transmitted Diseases (STD) Testing Market Value 2023, 2027 &amp; 2031, By Disease Type, ($Million)

Table 04 Global Sexually Transmitted Diseases (STD) Testing Market Value 2023, 2027 &amp; 2031, By Region, ($Million)

Table 05 Global Sexually Transmitted Diseases (STD) Testing Market Share 2023, 2027 &amp; 2031 (%), By Product Type ($Million)

Table 06 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Product Type, 2022&ndash;2031 ($Million)

Table 07 Global Sexually Transmitted Diseases (STD) Testing Market Share 2023, 2027 &amp; 2031 (%), By Location of Test ($Million)

Table 08&nbsp; Global Sexually Transmitted Diseases (STD) Testing Market Value , By Location of Test, 2022&ndash;2031 ($Million)

Table 09 Global Sexually Transmitted Diseases (STD) Testing Market Share 2023, 2027 &amp; 2031 (%), By Disease Type ($Million)

Table 10&nbsp; Global Sexually Transmitted Diseases (STD) Testing Market Value , By Disease Type, 2022&ndash;2031 ($Million)

Table 11 Global Sexually Transmitted Diseases (STD) Testing Market Share 2023, 2027 &amp; 2031 (%), By Region ($Million)

Table 12 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Region, 2022&ndash;2031 ($Million)

Table 13 North America Sexually Transmitted Diseases (STD) Testing Market Value , By Product Type, 2023&ndash;2031($Million)

Table 14 North America Sexually Transmitted Diseases (STD) Testing Market Value , By Location of Test, 2023&ndash;2031($Million)

Table 15 North America Sexually Transmitted Diseases (STD) Testing Market Value , By Disease Type, 2023&ndash;2031($Million)

Table 16 North America Sexually Transmitted Diseases (STD) Testing Market Value , By Country, 2023&ndash;2031($Million)

Table 17 South America Sexually Transmitted Diseases (STD) Testing Market Value , By Product Type, 2023&ndash;2031($Million)

Table 18 South America Sexually Transmitted Diseases (STD) Testing Market Value , By Location of Test, 2023&ndash;2031($Million)

Table 19 South America Sexually Transmitted Diseases (STD) Testing Market Value , By Disease Type, 2023&ndash;2031($Million)

Table 20 South America Sexually Transmitted Diseases (STD) Testing Market Value , By Country, 2023&ndash;2031($Million)

Table 21 Europe Sexually Transmitted Diseases (STD) Testing Market Value , By Product Type, 2023&ndash;2031($Million)

Table 22 Europe Sexually Transmitted Diseases (STD) Testing Market Value , By Location of Test, 2023&ndash;2031($Million)

Table 23 Europe Sexually Transmitted Diseases (STD) Testing Market Value , By Disease Type, 2023&ndash;2031($Million)

Table 24 Europe Sexually Transmitted Diseases (STD) Testing Market Value, By Country, 2023&ndash;2031($Million)

Table 25 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Value , By Product Type, 2023&ndash;2031($Million)

Table 26 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Value , By Location of Test, 2023&ndash;2031($Million)

Table 27&nbsp; Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Value , By Disease Type, 2023&ndash;2031($Million)

Table 28 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Value , By Country, 2023&ndash;2031($Million)

Table 29&nbsp; Middle East &amp; Africa Sexually Transmitted Diseases (STD) Testing Market Value , By Product Type, 2023&ndash;2031($Million)

Table 30&nbsp; Middle East &amp; Africa Sexually Transmitted Diseases (STD) Testing Market Value, By Location of Test, 2023&ndash;2031($Million)

Table 31&nbsp; Middle East &amp; Africa Sexually Transmitted Diseases (STD) Testing Market Value, By Disease Type, 2023&ndash;2031($Million)

Table 32 Roche Diagnostics: Overview

Table 33&nbsp; Roche Diagnostics: Product Portfolio

Table 34 Roche Diagnostics: Key Developments

Table 35&nbsp; Bio-Rad Laboratories: Overview

Table 36 Bio-Rad Laboratories: Product Portfolio

Table 37&nbsp; Bio-Rad Laboratories: Key Developments

Table 38 Hologic, Inc: Overview

Table 39 Hologic, Inc: Product Portfolio

Table 40 Hologic, Inc: Key Developments

Table 41 Merck And Company Inc: Overview

Table 42 Merck And Company Inc: Product Portfolio

Table 43 Merck And Company Inc: Key Developments

Table 44 Becton Dickinson &amp; Company: Overview

Table 45 Becton Dickinson &amp; Company: Product Portfolio

Table 46 Becton Dickinson &amp; Company: Key Developments

Table 47 Cepheid, Inc: Overview

Table 48 Cepheid, Inc: Product Portfolio

Table 49 Cepheid, Inc: Key Developments

Table 50 Danaher Corporation: Overview

Table 51 Danaher Corporation: Product Portfolio

Table 52 Danaher Corporation: Kg: Key Developments

Table 53 Affymetrix, Inc: Overview

Table 54 Affymetrix, Inc: Product Portfolio

Table 55 Affymetrix, Inc: Key Developments

Table 56 DiaSorin: Overview

Table 57 DiaSorin: Product Portfolio

Table 58 DiaSorin: Key Developments

Table 59 Abbott Laboratories: Overview

Table 60 Abbott Laboratories: Product Portfolio

Table 61 Abbott Laboratories: Key Developments

List of Figures

Figure 01 Global Sexually Transmitted Diseases (STD) Testing Market Share, 2022 &amp; 2031 (%), By Product Type

Figure 02 Global Sexually Transmitted Diseases (STD) Testing Market Share, 2023 &amp; 2031(%), By Location of Test

Figure 03 Global Sexually Transmitted Diseases (STD) Testing Market Share, 2023 &amp; 2031(%), By Disease Type

Figure 04 Global Sexually Transmitted Diseases (STD) Testing Market Share, 2023 &amp; 2031(%), By Region

Figure 05 Global Sexually Transmitted Diseases (STD) Testing Market Value, 2023 - 2031 And Year On Year Growth

Figure 06 Global Sexually Transmitted Diseases (STD) Testing Market Year On Year Growth 2022 To 2031 (%), By Product Type

Figure 07 Global Sexually Transmitted Diseases (STD) Testing Market Value, By Thermal Cyclers, 2023&ndash;2031($Million)

Figure 08 Global Sexually Transmitted Diseases (STD) Testing Market Value, By Lateral Flow Readers, 2023&ndash;2031($Million)

Figure 09 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Flow Cytometers, 2023&ndash;2031($Million)

Figure 10 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Differential Light Scattering Machines, 2023&ndash;2031($Million)

Figure 11 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Others, 2023&ndash;2031($Million)

Figure 12 Global Sexually Transmitted Diseases (STD) Testing Market Year On Year Growth 2022 To 2031 (%), By Location of Test

Figure 13 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Laboratory Testing, 2023&ndash;2031($Million)

Figure 14 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Point Of Care Testing, 2023&ndash;2031($Million)

Figure 15 Global Sexually Transmitted Diseases (STD) Testing Market Year On Year Growth 2022 To 2031 (%), By Disease Type

Figure 16 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Chlamydia, 2023&ndash;2031($Million)

Figure 17&nbsp; Global Sexually Transmitted Diseases (STD) Testing Market Value , By Gonorrhea, 2023&ndash;2031($Million)

Figure 18 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Syphilis, 2023&ndash;2031($Million)

Figure 19&nbsp; Global Sexually Transmitted Diseases (STD) Testing Market Share (%), By Human Immunodeficiency Virus/Aids, 2022 &amp; 2031

Figure 20 Global Sexually Transmitted Diseases (STD) Testing Market Share (%), By Trichomoniasis, 2022 &amp; 2031

Figure 21 Global Sexually Transmitted Diseases (STD) Testing Market Value , By Others, 2023&ndash;2031($Million)

Figure 22&nbsp; &nbsp; Global Sexually Transmitted Diseases (STD) Testing Market Year On Year Growth 2022 To 2031 (%), By Region

Figure 23 &nbsp; &nbsp; North America Sexually Transmitted Diseases (STD) Testing Market Value , 2023&ndash;2031($Million)

Figure 24 &nbsp; &nbsp; North America Sexually Transmitted Diseases (STD) Testing Market Share (%), By Product Product Type, 2023&ndash;2031($Million)

Figure 25 &nbsp; &nbsp; North America Sexually Transmitted Diseases (STD) Testing Market Share (%), By Location of Test, 2023&ndash;2031($Million)

Figure 26 &nbsp; &nbsp; North America Sexually Transmitted Diseases (STD) Testing Market Share (%), By Disease Type, 2023&ndash;2031($Million)

Figure 27 &nbsp; &nbsp; North America Sexually Transmitted Diseases (STD) Testing Market Share (%), By Countries, 2023&ndash;2031($Million)

Figure 28&nbsp; &nbsp; South America Sexually Transmitted Diseases (STD) Testing Market Value , 2023&ndash;2031($Million)

Figure 29 &nbsp; &nbsp; South America Sexually Transmitted Diseases (STD) Testing Market Share (%), By Product Product Type, 2023&ndash;2031($Million)

Figure 30 &nbsp; South America Sexually Transmitted Diseases (STD) Testing Market Share (%), By Location of Test, 2023&ndash;2031($Million)

Figure 31 South America Sexually Transmitted Diseases (STD) Testing Market Share (%), By Disease Type, 2023&ndash;2031($Million)

Figure 32 South America Sexually Transmitted Diseases (STD) Testing Market Share (%), By Countries, 2023&ndash;2031($Million)

Figure 33 Europe Sexually Transmitted Diseases (STD) Testing Market Value , 2023&ndash;2031($Million)

Figure 34 Europe Sexually Transmitted Diseases (STD) Testing Market Share (%), By Product Product Type, 2023&ndash;2031($Million)

Figure 35 Europe Sexually Transmitted Diseases (STD) Testing Market Share (%), By Location of Test, 2023&ndash;2031($Million)

Figure 36 Europe Sexually Transmitted Diseases (STD) Testing Market Share (%), By Disease Type, 2023&ndash;2031($Million)

Figure 37 Europe Sexually Transmitted Diseases (STD) Testing Market Share (%), By Countries, 2023&ndash;2031($Million)

Figure 38 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Value , 2023&ndash;2031($Million)

Figure 39 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Share (%), By Product Product Type, 2023&ndash;2031($Million)

Figure 40 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Share (%), By Location of Test, 2023&ndash;2031($Million)

Figure 41 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Share (%), By Disease Type, 2023&ndash;2031($Million)

Figure 42 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Share (%), By Countries, 2023&ndash;2031($Million)

Figure 43&nbsp; Middle East And Africa Sexually Transmitted Diseases (STD) Testing Market Value , 2023&ndash;2031($Million)

Figure 44&nbsp; Middle East And Africa Sexually Transmitted Diseases (STD) Testing Market Share (%), By Product Product Type, 2023&ndash;2031($Million)

Figure 45&nbsp; Middle East And Africa Sexually Transmitted Diseases (STD) Testing Market Share (%), By Location of Test, 2023&ndash;2031($Million)

Figure 46 &nbsp; &nbsp; Middle East And Africa Sexually Transmitted Diseases (STD) Testing Market Share (%), By Disease Type, 2023&ndash;2031($Million)

Figure 47&nbsp; &nbsp; Roche Diagnostics: Financials

Figure 48&nbsp; &nbsp; Bio-Rad Laboratories: Financials

Figure 49&nbsp; &nbsp; Hologic, Inc: Financials

Figure 50 &nbsp; DiaSorin: Financials

Figure 51&nbsp; &nbsp; Becton Dickinson &amp; Company: Financials

Figure 52&nbsp; &nbsp; Cepheid, Inc: Financials

Figure 53 &nbsp; &nbsp; Danaher Corporation: Financials

Figure 54&nbsp; &nbsp; Affymetrix, Inc: Financials

Figure 55&nbsp; &nbsp; Merck And Company Inc: Financials

Figure 56&nbsp; &nbsp; Abbott Laboratories: Financials

Sexually Transmitted Diseases (STD) Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Chlamydia Infection Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 01

Starting from

Syphilis Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 February 29

Starting from

HIV Diagnostics Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 February 03

Starting from